DBL MORPHINE SULFATE INJECTION 10 mg/ml
Product details
Registration number: SIN00757P
Classification: Prescription Only
Active ingredients: MORPHINE SULPHATE
Strength: 10 mg/ml
Dosage form: INJECTION
Route: SUBCUTANEOUS; INTRAMUSCULAR
Registrant: PFIZER PRIVATE LIMITED
ATC code: N02AA01
HSA approval date: 4 May 1988
Manufacturer(s): Siegfried Hameln GmbH
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for DBL MORPHINE SULFATE INJECTION 10 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN00757P
Classification: Prescription Only
What active ingredients and strength are recorded for DBL MORPHINE SULFATE INJECTION 10 mg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: MORPHINE SULPHATE
Strength: 10 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for DBL MORPHINE SULFATE INJECTION 10 mg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: SUBCUTANEOUS; INTRAMUSCULAR
Who is the recorded registrant for DBL MORPHINE SULFATE INJECTION 10 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: PFIZER PRIVATE LIMITED
Which manufacturers and countries are listed for DBL MORPHINE SULFATE INJECTION 10 mg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Siegfried Hameln GmbH
Manufacturing country/countries: GERMANY
Where can I look up DBL MORPHINE SULFATE INJECTION 10 mg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN00757P or the exact product name DBL MORPHINE SULFATE INJECTION 10 mg/ml. The general register link does not preselect this product.
What are the source dates for this DBL MORPHINE SULFATE INJECTION 10 mg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this DBL MORPHINE SULFATE INJECTION 10 mg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN00757P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)